News

Article

Gerresheimer Adds Ready-to-Fill Vials to Primary Packaging Portfolio

The ready-to-fill packaging solutions for vials are based on Ompi EZ-fill packaging design.

Gerresheimer, supplier of primary packaging solutions for the pharmaceutical industry, announced that it is adding to its portfolio ready-to-fill (RTF) vials. Vials that are ready to fill have been washed and sterilized and are provided in trays or in nests and tubs. These vials offer flexibility and reduce complexity because customers can immediately fill the vials without any further process. Gerresheimer and Ompi (a Stevanato Group Brand) have signed an agreement that allows Gerresheimer to use the Ompi EZ-fill packaging technology.

Vials are the standard primary packaging for parenteral drugs. Gerresheimer’s portfolio has vials in all sizes and that comply with international standards and pharmacopoeia requirements. The new Gx RTF vial portfolio will be based on already established quality offerings for vials such as PharmaPlus and Elite Glass. By adapting this knowledge to vials and combining it with the Ompi EZ-fill packaging solution, customers can source one identically packed vial from two suppliers.

Gerresheimer has been producing RTF glass syringes for more than 15 years and has recently launched RTF COP syringes produced in Europe.

Source: Gerresheimer

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content